Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Feb 19, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Erez Raphael, Chief Executive Officer, is scheduled to participate and host...
Jan 27, 2021Expands DarioHealth's multi-condition platform into the $213 billion musculoskeletal market and creates one of the most comprehensive digital health platformsDarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the signing of a definitive agreement to acquire digital musculoskeletal (MSK) company...
-
Jan 21, 2021Digital health executive Chris Chan held prior roles at Mercer, Willis Towers Watson, and SleepQuest
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the appointment of Chris Chan as Senior Vice President of Employer Sales. Mr. Chan will...
-
Jan 13, 2021Dr. Marilyn Ritholz, psychologist at Joslin Diabetes Center, a Harvard Medical School affiliate, and Dr. David Horwitz, former Global Chief Medical Officer of Johnson and Johnson Diabetes Institute, will help guide strategic and development roadmap
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Dr. Marilyn Ritholz and Dr. David Horwitz will join Chairman Eric Milledge on its...
- Jan 7, 2021Prior senior management roles at Omada Health, American Well, AIG, United Healthcare, and Humana
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the appointment of Claudia Rimerman Kraut as Vice President of Broker and Consultant...
- Jan 5, 2021Partnership with Vitality Group activates Dario's penetration into the self-insured employer market.
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the Company has entered into an agreement to provide its digital therapeutics...
- Dec 22, 2020Agreement expands Dario's provider-centric RPM offering to one of the largest integrated healthcare systems in New Mexico
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the Company has entered into an agreement to provide its remote patient monitoring...
- Nov 24, 2020Dario's top-rated digital diabetes tools and coaching will be available to eligible employees and their dependents starting January 1, 2021
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today that it has signed a contract to provide its digital therapeutics solution to eligible...
- Nov 19, 2020- 20th Annual Diabetes Technology Society meeting presentation documents outcomes in Dario study of 940 members
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, presented results from a new clinical study of 940 members at the 20th Annual Diabetes Technology Society...
- Nov 12, 2020Ramp up of U.S. commercial sales and marketing infrastructure resulting in B2B2C pipeline growth
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the third quarter 2020 and provided a corporate and commercial update....
-
Nov 4, 2020Earnings Discussion and Business Update Scheduled for 9:00 am Eastern Time
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it would release its second quarter ended September 30, 2020,...
- Oct 13, 2020DarioHealth selected after careful vetting of numerous digital therapeutics providers.
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced that Vitality Group has chosen the company's digital therapeutics solutions for inclusion in...
- Sep 21, 2020Agreement extends DarioHealth's reach into HMC's vast multi-employer welfare fund and employer client base through which HMC is currently managing more than one million members
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, and HMC HealthWorks, a 40-year veteran in healthcare management with clinically-integrated models of care...
-
Sep 16, 202040+ year healthcare career includes serving as Company Group Chairman at LifeScan, Inc., a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ)
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company's newly-established...
-
Aug 13, 2020Observational study results demonstrate improved blood pressure and glycemic control for patients suffering from hypertensive blood pressure and diabetes who used the Dario platform
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual...
- Aug 12, 2020Advanced discussions with health plans and self-insured employers furthering our transformation to a B2B2C digital therapeutics leader
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter 2020 and provided a corporate and commercial update....
- Aug 7, 2020Earnings Discussion and Business Update Scheduled for 9:00 am Eastern Time
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its second quarter ended June 30, 2020 financial...
-
Jul 31, 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it closed a private placement transaction with accredited investors, including...
-
Jul 20, 2020DarioHealth Enters UK Remote Patient Monitoring (RPM) Market Through Agreement with Williams MedicalAgreement makes the DarioHealth RPM solution available to chronic care patients at general practices across the UK and Ireland
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced that the company has entered into a new strategic partnership with Williams Medical to make the...
-
Jul 6, 2020Addition adds nearly 30 years of senior health plan leadership expertise to the company's Board
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has appointed veteran health plan executive Dennis A. Matheis to its Board...
- Jun 18, 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management...
- Jun 17, 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that Omar Manejwala, M.D., Chief Medical Officer, will present at the virtual Going Digital:...
- Jun 15, 2020Demonstrated a eA1c reduction of 1.42% which was sustained for two years
DarioHealth Corp. (Nasdaq: DRIO), a leading global digital therapeutics (DTx) company, presented the results of two new studies at the American Diabetes Association's (ADA) 80th Scientific...
- Jun 11, 2020Leverages Dario's flexible AI-driven platform to facilitate rapid implementation and potential revenue in 2020
DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has signed its first two remote patient monitoring (RPM) agreements. Remote...